Spyre Therapeutics Inc. (SYRE) — Capital Reinvestment Ratio

Latest as of June 2021: 0.01x

Spyre Therapeutics Inc. (SYRE) has a Capital Reinvestment Ratio of 0.01x as of June 2021, meaning it reinvests 0% of its operating cash flow ($2.08 Million) in capital expenditures ($30.00K). See free cash flow generation of Spyre Therapeutics Inc. to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$2.08 Million

USD

Capital Expenditures

$30.00K

USD

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for Spyre Therapeutics Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Spyre Therapeutics Inc. from None to None. For live market cap and broader valuation context, see Spyre Therapeutics Inc. market cap and net worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow